In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS merges with the three Red Cross testing laboratories located in Charlotte, Portland and St. Loui...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...